Key Points
- SVP Mark Brosius sold 2,362 shares on March 4 at an average price of $498.68 for $1,177,882.16, and a series of recent sales (including additional March and December transactions) reduced his direct ownership by about 39.93%.
- Intuitive Surgical shares traded down 2.8% to $482.76, with a one‑year range of $425.00–$603.88, a market cap of $171.44 billion and a trailing P/E of 61.19.
- The company reported an EPS beat ($2.53 vs. $2.27 expected) and 18.8% revenue growth for the quarter, and analysts maintain a consensus "Moderate Buy" rating with a $615.86 target price.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) SVP Mark Brosius sold 648 shares of Intuitive Surgical stock in a transaction on Tuesday, March 3rd. The shares were sold at an average price of $488.10, for a total value of $316,288.80. Following the completion of the transaction, the senior vice president owned 5,916 shares of the company's stock, valued at approximately $2,887,599.60. The trade was a 9.87% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Mark Brosius also recently made the following trade(s):
- On Thursday, March 5th, Mark Brosius sold 648 shares of Intuitive Surgical stock. The stock was sold at an average price of $495.20, for a total transaction of $320,889.60.
- On Wednesday, March 4th, Mark Brosius sold 2,362 shares of Intuitive Surgical stock. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16.
- On Monday, December 15th, Mark Brosius sold 464 shares of Intuitive Surgical stock. The stock was sold at an average price of $548.49, for a total transaction of $254,499.36.
- On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00.
Intuitive Surgical Stock Down 1.9%
NASDAQ:ISRG traded down $9.63 during trading hours on Friday, hitting $487.07. 984,254 shares of the stock were exchanged, compared to its average volume of 2,032,338. The company has a market capitalization of $172.97 billion, a P/E ratio of 61.73, a price-to-earnings-growth ratio of 3.86 and a beta of 1.66. The company's 50 day moving average is $523.39 and its two-hundred day moving average is $511.99. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts' consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the previous year, the company posted $2.21 earnings per share. The firm's quarterly revenue was up 18.8% on a year-over-year basis. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Analyst Ratings Changes
Several equities analysts recently weighed in on ISRG shares. TD Cowen upgraded shares of Intuitive Surgical to a "strong-buy" rating in a report on Tuesday, January 27th. The Goldman Sachs Group restated a "buy" rating and issued a $714.00 price target on shares of Intuitive Surgical in a research report on Friday, January 9th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Intuitive Surgical in a report on Monday, December 29th. HSBC increased their target price on Intuitive Surgical from $644.00 to $653.00 and gave the company a "buy" rating in a research note on Monday, January 26th. Finally, Wall Street Zen lowered Intuitive Surgical from a "buy" rating to a "hold" rating in a research report on Saturday, February 7th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $615.86.
Read Our Latest Stock Report on ISRG
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of ISRG. Riversedge Advisors LLC lifted its stake in Intuitive Surgical by 1.9% in the 4th quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider's stock valued at $510,000 after purchasing an additional 17 shares during the last quarter. Fiduciary Financial Group LLC boosted its stake in shares of Intuitive Surgical by 2.1% during the 4th quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider's stock worth $521,000 after acquiring an additional 19 shares during the period. Prosperity Consulting Group LLC increased its holdings in shares of Intuitive Surgical by 0.5% during the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider's stock worth $1,804,000 after acquiring an additional 19 shares during the last quarter. Rossmore Private Capital lifted its holdings in Intuitive Surgical by 2.0% during the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider's stock valued at $446,000 after purchasing an additional 20 shares during the last quarter. Finally, Activest Wealth Management lifted its stake in shares of Intuitive Surgical by 21.7% during the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider's stock worth $50,000 after buying an additional 20 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
